Generative AI

The WODMDX 2026 expo returns to Shanghai, leveraging a unique 'precision matching' model to connect global tech with China's industrial giants.

Galloway Capital Partners takes a 5.44% stake in Chegg, arguing the ed-tech firm is undervalued and a strategic split could revive its fortunes.

Jacksonville agency Dion Marketing lands a major account, leveraging AI and SEO to boost local visibility for 39 Monster Mini Golf franchise locations.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?

From commercial fleets to combat readiness, Xos targets the defense sector with its grid-independent mobile charging platform for military operations.

American Public Media's new Inform Media Network consolidates dozens of stations, offering advertisers a brand-safe path to a premium podcast audience.

A new survey shows AI-aware customers are forcing brands to rethink everything. Consumers now use their own AI tools for speed, upending traditional CX.

Ann Arbor startup Adrenaline Interactive lands a $1M prize to revolutionize in-game ads, signaling Michigan's push to become a tech innovation hub.

Contrary to hype, AI in drug discovery demands more physical lab work. A new report names Carterra a key winner in this surprising new paradigm.

Temasek-backed Xora Innovation hires Eric Rosenblum to lead its U.S. expansion, aiming to capture the next wave of AI and deep tech investment.

Debuting at SIR 2026, DeepSight's NeedleVue Mini aims to democratize advanced procedural guidance by upgrading existing ultrasound systems everywhere.

A new platform with 500+ AI agents promises to continuously hack companies, find real exploits, and fix code—all without human intervention. Is this the future?

With its 2026 roadmap, Reallusion blends generative AI and traditional workflows, promising photorealistic characters and new creative freedom for artists.

The eyecare tech leader will demo its redesigned EHR at ASCRS 2026, promising streamlined workflows. But can it stand out in a competitive market?

A stunning Q1 2026 revival shows SPACs are not dead. Fueled by veteran sponsors and a focus on AI and defense, a new era for public listings may be dawning.

As companies spend billions on AI with little to show, new analytics platforms aim to measure what's actually working—and what's just a waste of money.

Rune Labs launches StrivePD Guardian, an AI companion using Anthropic's Claude and a massive dataset to offer 24/7 personalized support for patients.

With a new MD and key promotions, the firm signals a strategic push to deepen its human capital and investor relations for its next growth phase.

The university received historic accreditation for a Riyadh campus, a landmark move aligning with Saudi Arabia's ambitious Vision 2030 economic reforms.